SEC Form 4/A · accession 0001144204-15-059186
BRAINSTORM CELL THERAPEUTICS INC. · BCLI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Chaim Lebovits
Officer — See Remarks
Period of report
Sep 28, 2015
Accepted (ET)
Oct 13, 2015 · 4:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001137883
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.45 | Sep 28, 2015 | A | 369,619 | A | Sep 28, 2015 | Sep 28, 2025 | Common Stock | 369,619 | 369,619 | D |
Explanation of responses
- F1The reporting person is amending the Form 4 originally filed to report this option grant, for the purpose of reflecting a corrected fully vested date. The option vests and becomes exercisable in 12 consecutive, equal monthly installments starting September 28, 2015, until fully vested on August 28, 2016.
Remarks
Chief Executive Officer & President